hercules™ balloon inflation catheter gained market launch approval in brazil2015-云顶国际

microport endovascular (shanghai) co ("microport® endovascular") recently gained the registration certificate for its in-house developed hercules™ balloon inflation catheter from brazil's national health surveillance agency.

hercules™ balloon inflation catheter is indicated for enhancing the vessel wall apositioning of self-expandable graft-stent. it can effectively enhance graft-stent expansion, avoid incomplete vessel wall apositioning, eliminate aneurysm endoleak risk, and ensure precise deployment.

hercules™ balloon inflation catheter is designed to work with microport® endovascular's hercules™ thoracic stent-graft system and hercules bifurcated stent-graft system. with hercules™ balloon inflation catheter's market launch approval in brazil, the entire serial of microport® endovascular's hercules™ products have been launched in the local market, which will better serve the need of surgeons and further expand the company's overseas market.

microport scientific corporation (the "group") is a leading medical device company with business focusing on innovating, manufacturing, and marketing high-quality and high-end medical devices globally. with a diverse portfolio of products now being used at an average rate of one for every 18 seconds in thousands of major hospitals around the world, the group maintains world-wide operations in a broad range of business segments including cardiovascular, orthopedic, electrophysiological, endovascular, neurovascular, surgical, diabetes care and endocrinal management, and others. microport® is dedicated to becoming a patient oriented global enterprise improve and reshape patient lives through application of innovative science and technology.